Divi’s, Teva Draw Warnings Over GMP Problems

Drug Industry Daily
A A
Divi’s Laboratories has been warned by the FDA for failing to meet current good manufacturing practice requirements, adding to the Indian drug manufacturer’s compliance woes.

To View This Article:

Login

Subscribe To Drug Industry Daily